Ellsworth Advisors, LLC Innoviva, Inc. Transaction History

Ellsworth Advisors, LLC

  • $382 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022
SELL
$14.32 - $19.88 $5,470 - $7,594
-382 Reduced 1.45%
25,876 $382,000
Q1 2022

Apr 21, 2022
SELL
$15.39 - $20.25 $45,138 - $59,393
-2,933 Reduced 10.05%
26,258 $480,000
Q4 2021

Jan 18, 2022
BUY
$15.91 - $18.72 $464,428 - $546,455
29,191 New
29,191 $504,000

Others Institutions Holding INVA

# of Institutions
228
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.21B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Ellsworth Advisors, LLC Portfolio

Follow Ellsworth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellsworth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email